The incidence of anti-mGluR5 encephalitis in clinical settings is remarkably low, mainly manifesting cognitive deficit, mental disorders, epilepsy, disturbance of consciousness, and sleep disorders. The gene discussed is GRM5; the disease is viral encephalitis.